Karo Pharma has received a milestone for the RORgamma project amounting to 2 million USD.
“This is the second milestone-payment for RORgamma. Very good news for the project” says Anders Lönner, Chairman of the Board.
For further information, please contact:
Henrik Palm, CFO,
Telephone +46 70 540 40 14 or
The information in this report is such that Karo Pharma is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on May 4, 2016 at 3.00 p.m. CET.